Former Chief Medical Officer · Vera Therapeutics, Inc. (VERA)

Celia Lin

A named executive officer of Vera Therapeutics in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,020,673

Salary $457,763Stock awards $0

FY2022: $1,585,950

3rd of 3 named executive officers at Vera Therapeutics by FY2023 total.

3 named officers on file for Vera Therapeutics, FY2023

Celia Lin’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • VERA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Vera Therapeutics’s whole pay program stands against its peers

  • Vera Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VERA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 3, 2024 (DEF 14A).

Free

Get Celia Lin’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Celia Lin compensation by year

Vera Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Vera Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$361,205$440,487$457,763
Bonus$150,000$0$0
Stock awards$0$232,500$0
Option awards$797,776$733,123$559,910
Non-equity incentive$134,616$176,840$0
Pension and deferred compensation$0$0$0
All other$0$3,000$3,000
Total$1,443,597$1,585,950$1,020,673

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Vera Therapeutics, Inc. DEF 14A filed April 3, 2024, accession 0001140361-24-017650, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Vera Therapeutics, Inc. filed document, accession 0001140361-24-017650. Every figure is read from that document and cited to the page and table it appears in. Filed April 3, 2024.

$1.4M
$1.6M
$1.0M
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU8,333$128,162—
Option5,992—$11.00
Option67,323—$3.94
Option28,390—$20.94
Option79,167—$7.87

Per the Outstanding Equity Awards at Fiscal Year-End table in Vera Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Vera Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Marshall FordycePresident and Chief Executive Officer$3,429,733
Sean GrantChief Financial Officer$1,761,820
Celia Lin · this pageFormer Chief Medical Officer$1,020,673

The full Vera Therapeutics compensation record

free company brief

This page is one person within Vera Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Vera Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Celia Lin's compensation dossier · One-time report. No refunds.